Regulation of antibody immunotherapy by fine-tuning FcR interactions

Video   Apr 22, 2013

 

About the Speaker


Mark Cragg is a Professor in Experimental Cancer Biology at the Cancer Sciences Division of Southampton University School of Medicine, UK. He obtained his PhD in 1998 and did his postdoctoral studies with Martin Glennie in Southampton and then Andreas Strasser at the Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. He has published over 60 papers, many in high impact journals such as the Journal of Clinical Investigation, PNAS, Plos Medicine and Blood and leads a dynamic research group interested in all aspects of how therapeutics such as antibodies result in tumour regression and how they can be improved.
Abstract

Monoclonal antibodies (mAb) represent a growing class of ‘block-buster’ cancer drugs and so understanding of their modes of action is critical. Here, we present evidence that different mAb interact with Fc receptors differently in order to achieve their therapeutic activities.

 
 
 
 

Recommended Videos

LeNeo - Fusion Instrument

Video

LeNeo fusion instrument is an automatic and single position electrical instrument that prepares glass disks for XRF as well as solutions (borate and peroxide) for AA and ICP analysis.

WATCH NOW

Immunology Wars: The Role of Monoclonal Antibodies

Video

Our immune systems are at war with cancer. This animation reveals how monoclonal antibodies can act as valuable reinforcements to shore up our defences – and help battle cancer.

WATCH NOW

Biggest Science News Stories of 2017

Video

We have seen some amazing scientific breakthroughs in 2017, here is a selection of our favourites.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE